Understanding how the vaginal microbiome helps clear Chlamydia infections
Official title: Prospective contributions of the vaginal microbiome and immune milieu to spontaneous Chlamydia trachomatis clearance
Funded at University of Maryland Baltimore · NIH-10820362 · Data updated 2026-11-12
This study is looking at how the natural balance of bacteria and the immune system in the vagina can help young women clear Chlamydia infections on their own, without needing antibiotics, to find ways to support this natural process and protect their reproductive health.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | August 1, 2024 |
| Project end | September 24, 2025 |
| Funding year | 2024 |
| Award (this year) | $76,996 |
| NIH project number | 1F32AI181170-01 |
| Project ID | NIH-10820362 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are young women aged 15-24 who are diagnosed with Chlamydia trachomatis infections.
✕Less likely to help
Patients who are not infected with Chlamydia trachomatis or those who have already received treatment may not benefit from this research.
What this research studies
This research investigates the role of the vaginal microbiome and immune system in the natural clearance of Chlamydia trachomatis infections, particularly in young women. It aims to identify specific characteristics of the vaginal environment that may contribute to the body's ability to eliminate the infection without antibiotics. By analyzing cervicovaginal samples from a large study, the research will explore how factors like bacterial composition and immune responses vary with the duration of the infection. The goal is to develop antibiotic-sparing strategies that enhance natural clearance and reduce the risk of long-term reproductive health issues.
Why it matters
Potential benefit: If successful, this research could lead to new approaches for treating Chlamydia infections that minimize the need for antibiotics and improve reproductive health outcomes.
How similar studies have gone: Previous research has shown that understanding the vaginal microbiome can influence treatment strategies for infections, suggesting potential for success in this novel approach.
Where this research is happening
-
University of Maryland Baltimore
Baltimore, United States Active
Researchers
- Principal investigator: Carter, Kayla a — University of Maryland Baltimore
- Study coordinator: Carter, Kayla a
Related research
Other NIH-funded projects on the same topics.
-
Resilient HIV Implementation for LGBTQ Youth in Africa and Beyond
A program to help young people ages 15–24 who are at risk for or living with HIV, especially sexual and gender minority youths, access better HIV prevention and care through real-world health practice improvements.
-
Algorithms to find HLA-E neoantigens for cancer immunotherapy
Aims to develop computer methods to discover tumor-specific targets presented by HLA-E to guide new T cell therapies for cancer.
-
NPRL2 loss and focal cortical dysplasia in epilepsy
This grant investigates how losing NPRL2 in the brain contributes to focal cortical dysplasia and epilepsy in children.
-
New way to make head and neck cancer treatments work better
A research project at the University of Maryland Baltimore aims to improve treatment for advanced head and neck cancer, with a focus on making cisplatin and newer therapies work better while reducing kidney side effects.
-
Genetics and function of inherited brain disorders that affect thinking and behavior
Scientists are studying how genes and cellular helpers shape brain development and why certain kids have intellectual disabilities and adaptive-behavior challenges.
-
Finding broadly protective antibodies against Crimean-Congo Hemorrhagic Fever
Researchers will study blood from people who survived CCHF to find human antibodies that protect against multiple virus variants, with early tests in animal models to check their breadth.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.